台股 » 智擎 » 個股財報 » 每月營收

智擎

(4162)
可現股當沖
  • 股價
    93.8
  • 漲跌
    ▼2.4
  • 漲幅
    -2.49%
  • 成交量
    846
  • 產業
    上櫃 生技醫療類股 ▼0.42%
  • 本地時間:14:30

    303人加入追蹤

    立即追蹤

智擎 (4162) 財務報表-每月營收
月營收報表

因應IFRSs國際會計準則,本報表在2013年以前為「個別營收」,2013年以後為「合併營收」。

智擎 (4162) 月營收分析比較圖

智擎 (4162) 月營收報表

年度/月份營業收入(單位:千元)累計營業收入(單位:千元)
單月營收去年同月營收單月月增率單月年增率累計營收去年累計營收累積年增率
2024/1022,11419,265-86.7%14.8%666,711599,61011.2%
2024/09166,833132,630541.3%25.8%644,597580,34511.1%
2024/0826,01329,5462.5%-11.9%477,764447,7156.7%
2024/0725,37883,766-83.5%-69.7%451,751418,1698%
2024/06154,098119,40477.7%29%426,373334,40327.5%
2024/0586,70026,382310.8%228.6%272,275214,99926.6%
2024/0421,10420,284-82.3%4%185,575188,617-1.6%
2024/03118,898122,610535.1%-3%164,471168,333-2.3%
2024/0218,72120,144-30.3%-7.1%45,57345,723-0.3%
2024/0126,85225,579-81.7%5%26,85225,5795%
2023/12126,579116,130496.1%9%747,423654,38314.2%
2023/1121,23420,34310.2%4.4%620,844538,25315.3%
2023/1019,26522,000-85.5%-12.4%599,610517,91015.8%
2023/09132,630103,828348.9%27.7%580,345495,91017%
2023/0829,54626,657-64.7%10.8%447,715392,08214.2%
2023/0783,76624,397-29.8%243.3%418,169365,42514.4%
2023/06119,404124,648352.6%-4.2%334,403341,028-1.9%
2023/0526,38222,87330.1%15.3%214,999216,380-0.6%
2023/0420,28419,378-83.4%4.7%188,617193,507-2.5%
2023/03122,610132,502508.7%-7.5%168,333174,129-3.3%
2023/0220,14415,887-21.2%26.8%45,72341,6279.8%
2023/0125,57925,740-74.6%-0.6%25,57925,740-0.6%
2022/12100,536164,621394.2%-38.9%638,789654,835-2.5%
2022/1120,34321,254-7.5%-4.3%538,253490,2149.8%
2022/1022,00017,926-78.8%22.7%517,910468,96010.4%
2022/09103,828136,617289.5%-24%495,910451,0349.9%
2022/0826,65722,2429.3%19.8%392,082314,41724.7%
2022/0724,39718,267-80.4%33.5%365,425292,17525.1%
2022/06124,648119,995445%3.9%341,028273,90824.5%
2022/0522,87318,46718%23.9%216,380153,91340.6%
2022/0419,37819,801-85.4%-2.1%193,507135,44642.9%
2022/03132,50279,127734%67.4%174,129115,64550.6%
2022/0215,88713,772-38.3%15.4%41,62736,51814%
2022/0125,74022,746-80.9%13.2%25,74022,74613.2%
2021/12134,525690,135532.9%-80.5%624,7391,056,012-40.8%
2021/1121,25482,68418.6%-74.3%490,214365,87734%
智擎明、後年新藥將有斬獲 歐洲藥證+一期臨床數據結果Anue鉅亨-2023/11/03
智擎 相關文章